Status:
COMPLETED
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
Lead Sponsor:
Abbott
Conditions:
Pharmacokinetics
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The objective of this study is to evaluate the potential PK interaction between ABT-335, atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.
Eligibility Criteria
Inclusion
- Healthy male or female subjects
Exclusion
- Clinically significant diseases or disorders
- Positive screens for drug and alcohol
- Pregnant or breast-feeding females
- Any history of surgery(ies) that might interfere with the gastrointestinal motility, pH or absorption
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00681525
Start Date
April 1 2008
Last Update
October 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 8087
Gainesville, Florida, United States, 32608